好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

The Combination of Clinical Features, Transcranial Doppler and ASPECTS Score in Predicting Outcome in IV rt-PA Treated Patients: The CLOTBUST Collaboration Study Group
Cerebrovascular Disease and Interventional Neurology
(-)
102
Authors/Disclosures
Muhammad S. Hussain, MD (Cleveland Clinic) Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiger Medical.
Andrei V. Alexandrov, MD (Department of Neurology, UTHSC) The institution of Dr. Alexandrov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovaSignal. Dr. Alexandrov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisc. Dr. Alexandrov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Alexandrov has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Society of Neuroimaging. Dr. Alexandrov has received publishing royalties from a publication relating to health care.
Andrew M. Demchuk, MD (Foothills Hospital/Calgary Stroke Program) Dr. Demchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Demchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lumosa. Dr. Demchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer/BMS. Dr. Demchuk has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer Ingelheim. Dr. Demchuk has received stock or an ownership interest from Circle NVI. Dr. Demchuk has received intellectual property interests from a discovery or technology relating to health care.
Georgios Tsivgoulis, MD, FAAN (NEURODIAGNOSTICS AND NEUROTHERAPEUTICS PC) Dr. Tsivgoulis has nothing to disclose.
Mathes Burke No disclosure on file
Abdul Salam Al Soliman, MSc No disclosure on file
Maher Saqqur, MD (University of Alberta) Dr. Saqqur has nothing to disclose.